Isolated office (white coat) hypertension
Continued use of office and ambulatory blood pressure measurements has allowed to identify a condition characterized by a persistently elevated office blood pressure and a persistently normal ambulatory one (18) . Most data indicate this condition (which occurs in about 10% (19) of the population) to represent a lesser cardiovascular risk than the condition characterized by both an office and an ambulatory blood pressure elevation. Conflicting data about prevalence of organ damage, cardiovascular risk and proneness to future hypertension make it still uncertain whether it represents a truly innocent phenomenon or not, however (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) .
This suggests that caution should be used when deciding whether these patients should or should not be treated. Non-drug treatment should always be implemented and drugs used in case of organ damage or an otherwise high risk profile. If treatment is not started a close follow-up is recommended. It is also recommended that patients having a 24h blood pressure greater than office blood pressure are identified because some studies suggest to be at high risk.
Masked hypertension (reverse white coat hypertension)
In reference to AMBP and home blood pressure measurement, it is possible to individualize patients whose BP values are abnormal in the office and normal outside the office. Recent epidemiological prospective studies suggest that this state might be an independent predictor of cardiovascular morbidity (30, [34] [35] [36] [37] [38] [39] .
Clinical use of blood pressure values within the 24 hours
Several blood pressure values within the 24 hours have been given clinical importance. Morning blood pressure use Blood pressure shows a steep rise from the asleep to the awake state and its resumption of physical activity. The only evidence that this phenomenon has clinical importance stands on its association with a morning peak incidence of coronary heart disease and stroke (40) , although in both instances a concomitant increase in platelet aggregability and reduction in fibrinolytic activity may play a role (41) . It seems nevertheless advisable for the physician to ensure that antihypertensive treatment lower blood pressure after arousal with no escape from the reduction seen in the remaining 24h time. Dipping and non-dipping Blood pressure falls at night but more so in some subjects than in others. This has led to the subdivision of hypertensive patients into dippers and non-dippers, based on a nocturnal blood pressure fall greater or less than 10% of the daytime values, respectively (40, 41) . This has drawbacks because the magnitude of night-time hypotension is poorly reproducible (42) (in relation to differences in sleep quality/depth) and a 10% cut off value is arbitrary (14).
Yet, several studies have shown night-time blood pressure to be related to organ damage and cardiovascular risk (43) (44) (45) (46) (47) (48) (49) (50) (51) and some have reported a superior prognostic value of nocturnal vs diurnal blood pressures (9). Although in most hypertensives day and night blood pressure values and changes with treatment are closely related (12, 42, 52, 53). In the clinical practice ambulatory blood pressure monitoring should definitely include the night period and treatment should ensure that both day and night time blood pressure values are reduced. Attention should be given to patients in which the night is associated with no reduction or even an increase in blood pressure because (provided that a sleepless night is excluded) this suggests the existence of a marked degree of vascular organ damage autonomic dysfunction and hypertension severity. Attention should also be given to subjects with a very pronounced reduction in night-time blood pressure (>20%, so-called extreme dippers) because of the possibility that this leads to brain under-perfusion, particularly if a further blood pressure fall is produced by treatment (54 (56) (57) (58) (59) . However, this measure is still in a research phase and should not yet be used for classification of patients' risk and assessment of efficacy of treatment.
Efficacy of antihypertensive treatment
ABPM has drastically improved the ability to assess the efficacy of antihypertensive treatment both in clinical studies and in medical practice (60) (61) (62) . In clinical trials advantages such as a greater reproducibility, the lack of placebo effect and the absence of an alerting-dependant pressure response (63) makes ABPM the ideal approach to quantify the antihypertensive effect of new antihypertensive drugs drug combination or non pharmacological measures. It makes also possible to study how suitable and consistent an antihypertensive effect is between two drug doses by indices such as the trough-to-peak ratio and the smoothness index (62) (63) (64) . To some extent this is also possible in the medical practice if ABPM is performed before and during treatment. A limitation, however, is that the blood pressure values to be reached by treatment in relation to the office blood pressure targets with documented protective properties are still incompletely known.
Conclusions
ABPM has opened new horizons for hypertension research and its progressively large use has had a positive impact on clinical practice. Its adoption can thus be recommended when facilities are available. Further research is needed, however, to obtain information on issues still not clear: Among them ambulatory blood pressure variability and targets by treatment, clinical importance of isolated clinic or white coat hypertension and relative value of information obtainable by blood pressure patterns within the 24 hours.
